Hearing evaluation and rehab system for congenital hearing loss
Part of Ear, nose & throat, Genetic & congenital clinical trials.
This study is developing a system to evaluate and improve hearing for people with congenital hearing loss. It compares participants who have hearing loss (and have used hearing aids, cochlear implants, or gene therapy) with healthy controls, to better understand and treat hearing challenges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have congenital hearing loss (hearing loss at birth), with hearing thresholds of 65 dB or more, and you’ve already had treatment like hearing aids, a cochlear implant, or gene therapy.
- You are between 1 and 35 years old.
- Your native language is Mandarin Chinese.
- You are willing to come for evaluations at set times and can follow instructions with help from a guardian if needed.
- You do not have other ear problems (like ear infections or Meniere's disease) or severe health conditions (like heart disease, hepatitis, weak immune system, or a history of organ transplant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who get a cochlear implant – a device that helps restore hearing. It tracks how well you hear over time and checks for any long-term benefits or problems.
This study looks at how well gene therapy or cochlear implants help restore hearing in people with severe hearing loss from birth. It compares the outcomes of these two treatments to see which is more effective.
This study looks for genetic causes of hearing loss in babies who did not pass their newborn hearing screening. It aims to help families understand why their child has hearing loss and may guide future care.
This trial tests an injection called EHT102 for children who have severe or profound hearing loss due to mutations in the Otoferlin gene. The goal is to see if the treatment can restore or improve hearing.
This trial tests a new cochlear implant device for people with severe or profound hearing loss. The implant may help you hear better by directly stimulating the hearing nerve, and the study will check if it is safe and works well.
This study follows people and families with autosomal dominant inherited hearing loss to better understand how it progresses. It may help researchers learn what to expect over time and guide future treatment planning.
Hear when a new Congenital Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.